SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
2.740
-0.050 (-1.79%)
At close: Mar 27, 2026, 4:00 PM EDT
2.690
-0.050 (-1.82%)
After-hours: Mar 27, 2026, 7:58 PM EDT
SeaStar Medical Holding Employees
SeaStar Medical Holding had 19 employees as of December 31, 2024. The number of employees increased by 7 or 58.33% compared to the previous year.
Employees
19
Change (1Y)
7
Growth (1Y)
58.33%
Revenue / Employee
$64,947
Profits / Employee
-$639,474
Market Cap
10.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 19 | 7 | 58.33% |
| Dec 31, 2023 | 12 | 3 | 33.33% |
| Dec 31, 2022 | 9 | 6 | 200.00% |
| Sep 30, 2022 | 8 | 5 | 166.67% |
| Jun 30, 2022 | 3 | - | - |
| Mar 31, 2022 | 3 | - | - |
| Dec 31, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| BioLineRx | 28 |
| Soligenix | 16 |
| NewcelX | 15 |
| BioVie | 13 |
| Cellectar Biosciences | 11 |
| Acurx Pharmaceuticals | 4 |
ICU News
- 3 days ago - SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 10 days ago - SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - GlobeNewsWire
- 20 days ago - SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th - GlobeNewsWire
- 24 days ago - SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) - GlobeNewsWire
- 2 months ago - SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces 2026 Milestones - GlobeNewsWire
- 2 months ago - SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - GlobeNewsWire